pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
ACT-903
Hematological Tumor
Alpha Cancer Technologies Inc
0 catalysts
Preclinical
ACXT-3102
Pancreatic Ductal Adenocarcinoma
Accuronix Therapeutics Inc
0 catalysts
Preclinical
ADC
Unspecified Cancer
Kind Pharmaceuticals
0 catalysts
Phase 2
ADCED-01
Soft Tissue Sarcoma
ADCendo ApS
← prev
page 8 of 62
next →
131
Pain89
Neurology1
0 catalysts
Phase 1
ADCT-701
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Chiome Bioscience Inc
0 catalysts
Phase 2
ADG-116
Solid Tumor
$ADAGAdagene Inc.
0 catalysts
Preclinical
ADI-002
Solid Tumor
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Preclinical
ADI-212
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$ACETAdicet Bio, Inc.
0 catalysts
Preclinical
ADP-2
Triple-Negative Breast Cancer (TNBC)
Adecto Pharmaceuticals Inc
0 catalysts
Phase 1
ADRX-0405
Gastric Cancer
Adcentrx Therapeutics Inc
0 catalysts
Phase 1
ADRX-0706
Cervical Cancer
Adcentrx Therapeutics Inc
0 catalysts
Phase 1
ADU-1805
Solid Tumor
Sairopa BV
0 catalysts
Phase 2
AFM-24I
Breast Cancer
Affimed GmbH
0 catalysts
Phase 1
AG-236
Polycythemia Vera
$AGIOAGIOS PHARMACEUTICALS, INC.
0 catalysts
Phase 1
AGEN-1571
Solid Tumor
$AGENAGENUS INC
0 catalysts
Phase 1
AGEN-1777
Colon Cancer
$AGENAGENUS INC
0 catalysts
Phase 1
AGEN-2373
Adrenal Gland Cancer
$AGENAGENUS INC
0 catalysts
Phase 1
AGX-101
Bile Duct Cancer (Cholangiocarcinoma)
Angiex Inc
0 catalysts
Phase 2
AGuIX
Glioblastoma Multiforme (GBM)
NH TherAguix SAS
0 catalysts
Phase 2
AI-081
Solid Tumor
OncoC4 Inc
0 catalysts
Phase 1
AIC-100
Anaplastic Thyroid Cancer
AffyImmune Therapeutics Inc
0 catalysts
Phase 1
AJ-111095
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
Ajax Therapeutics Inc
0 catalysts
Preclinical
AKT-105
Esophageal Cancer
ArKri Therapeutics
0 catalysts
Phase 1
AKY-1189
Cervical Cancer
$AKTSAktis Oncology, Inc.
0 catalysts
Phase 2
ALEP-02
Cervical Cancer
Alentis Therapeutics AG
0 catalysts
Phase 2
ALG.APV-527
Cervical Cancer
Alligator Bioscience AB
0 catalysts
Phase 1
ALLO-316
Metastatic Renal Cell Carcinoma
$ALLOAllogene Therapeutics, Inc.
0 catalysts
Phase 1
ALX-2004
Colorectal Cancer
$ALXOALX ONCOLOGY HOLDINGS INC
0 catalysts
Preclinical
AM-401
Colorectal Cancer
$CYTOFAltamira Therapeutics Ltd.
0 catalysts
Preclinical
AMA-001
Glioblastoma Multiforme (GBM)
Amasa Therapeutics Inc
0 catalysts